Akers Biosciences Signs a Further Independent Sales Representative Organization for Heparin PF4 Rapid Test Covering Additional 12 States
AKERS BIOSCIENCES INC COMMON S (AKER)
US:NASDAQ Investor Relations:
akersbio.com/investor-center
Company Research
Source: GlobeNewswire
THOROFARE, N.J.,, July 18, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces another agreement with a major Independent Sales Representative (ISR) organization, adding sales and marketing coverage for the Company’s rapid test for heparin-induced thrombocytopenia (HIT) across an additional 12 states. The agreement with Appleton Medical Services, based in St. Louis, Missouri, will place Akers Bio’s flagship HIT test into the hands of a further 14 speciality medical product sales representatives, focused on implementing solutions into the clinical pathway. Appleton Medical Services will target clinical end-users of, and those able to prescribe, HIT tests, including surgeons and surgical teams. Their teams will provide sales and marketing exposure for PIFA Heparin/PF4 Rapid Assay products in Indiana, Kentucky, Minnesota, Illinois, Wisconsin, Mississippi, Louisian
Show less
Read more
Impact Snapshot
Event Time:
AKER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKER alerts
High impacting AKERS BIOSCIENCES INC COMMON S news events
Weekly update
A roundup of the hottest topics